Doxylamine succinate is a first-generation antihistamine drug classified as an H1 receptor antagonist with potent anticholinergic properties, widely used for the symptomatic treatment of allergic rhinitis… Read more
Doxylamine succinate is a first-generation antihistamine drug classified as an H1 receptor antagonist with potent anticholinergic properties, widely used for the symptomatic treatment of allergic rhinitis and insomnia due to its sedative effects. Maintaining rigorous quality control requires high-quality reference standards of the active pharmaceutical ingredient, as well as its related impurities and metabolites. Analytical laboratories utilize these compounds, including specific degradation products such as desmethyl doxylamine and 1-phenyl-1-(pyridin-2-yl)ethan-1-ol, to perform accurate impurity profiling and method validation. By incorporating these well-characterized reference materials and stable isotope labelled compounds into testing protocols, researchers ensure regulatory compliance and the precision of analytical assays throughout the pharmaceutical development lifecycle. This collection supports reliable quantitative analysis and the identification of potential process-related or degradant impurities in complex drug substance and drug product matrices.